Eam Investors, LLC Fulgent Genetics, Inc. Transaction History

Eam Investors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$31.01 - $52.1 $1.29 Million - $2.17 Million	-41,703 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$15.89 - $50.51 $174,948 - $556,115	11,010 Added 35.87%	41,703 $1.67 Million
Q2 2020 Aug 13, 2020	SELL	$8.89 - $18.28 $1.22 Million - $2.51 Million	-137,209 Reduced 81.72%	30,693 $491,000
Q1 2020 May 13, 2020	SELL	$6.75 - $19.75 $194,636 - $569,491	-28,835 Reduced 14.66%	167,902 $1.81 Million
Q4 2019 Feb 11, 2020	BUY	$9.29 - $15.82 $972,170 - $1.66 Million	104,647 Added 113.64%	196,737 $2.54 Million
Q3 2019 Nov 13, 2019	BUY	$5.96 - $12.81 $548,856 - $1.18 Million	92,090 New	92,090 $957,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.